Annelies Vantieghem

1.5k total citations
12 papers, 1.2k citations indexed

About

Annelies Vantieghem is a scholar working on Pulmonary and Respiratory Medicine, Toxicology and Molecular Biology. According to data from OpenAlex, Annelies Vantieghem has authored 12 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 5 papers in Toxicology and 4 papers in Molecular Biology. Recurrent topics in Annelies Vantieghem's work include Photodynamic Therapy Research Studies (9 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Nanoplatforms for cancer theranostics (3 papers). Annelies Vantieghem is often cited by papers focused on Photodynamic Therapy Research Studies (9 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Nanoplatforms for cancer theranostics (3 papers). Annelies Vantieghem collaborates with scholars based in Belgium and United States. Annelies Vantieghem's co-authors include Patrizia Agostinis, Wilfried Merlevede, Peter de Witte, Jackie R. Vandenheede, Zerihun Assefa, Peter Vandenabeele, Wim Declercq, Jacques Piette, Yan Xu and Yvette Habraken and has published in prestigious journals such as Journal of Biological Chemistry, FEBS Letters and Biochemical Pharmacology.

In The Last Decade

Annelies Vantieghem

12 papers receiving 1.2k citations

Peers

Annelies Vantieghem
Kashif Azizuddin United States
Annelies Vantieghem
Citations per year, relative to Annelies Vantieghem Annelies Vantieghem (= 1×) peers Kashif Azizuddin

Countries citing papers authored by Annelies Vantieghem

Since Specialization
Citations

This map shows the geographic impact of Annelies Vantieghem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annelies Vantieghem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annelies Vantieghem more than expected).

Fields of papers citing papers by Annelies Vantieghem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annelies Vantieghem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annelies Vantieghem. The network helps show where Annelies Vantieghem may publish in the future.

Co-authorship network of co-authors of Annelies Vantieghem

This figure shows the co-authorship network connecting the top 25 collaborators of Annelies Vantieghem. A scholar is included among the top collaborators of Annelies Vantieghem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annelies Vantieghem. Annelies Vantieghem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Piette, Jacques, Cédric Volanti, Annelies Vantieghem, et al.. (2003). Cell death and growth arrest in response to photodynamic therapy with membrane-bound photosensitizers. Biochemical Pharmacology. 66(8). 1651–1659. 105 indexed citations
2.
Agostinis, Patrizia, Annelies Vantieghem, Wilfried Merlevede, & Peter de Witte. (2002). Hypericin in cancer treatment: more light on the way. The International Journal of Biochemistry & Cell Biology. 34(3). 221–241. 384 indexed citations
3.
Vantieghem, Annelies, Yan Xu, Zerihun Assefa, et al.. (2002). Phosphorylation of Bcl-2 in G2/M Phase-arrested Cells following Photodynamic Therapy with Hypericin Involves a CDK1-mediated Signal and Delays the Onset of Apoptosis. Journal of Biological Chemistry. 277(40). 37718–37731. 105 indexed citations
4.
Vantieghem, Annelies, Yan Xu, Wim Declercq, et al.. (2001). Different Pathways Mediate Cytochrome c Release After Photodynamic Therapy with Hypericin. Photochemistry and Photobiology. 74(2). 133–133. 54 indexed citations
5.
Delaey, Els, et al.. (2001). In Vitro Photobiological Evaluation of Rhodac, A New Rhodacyanine Photosensitizer¶. Photochemistry and Photobiology. 74(2). 331–331. 3 indexed citations
6.
Agostinis, Patrizia, Zerihun Assefa, Annelies Vantieghem, et al.. (2000). Apoptotic and anti-apoptotic signaling pathways induced by photodynamic therapy with hypericin. Advances in Enzyme Regulation. 40(1). 157–182. 41 indexed citations
7.
Assefa, Zerihun, Annelies Vantieghem, Marjan Garmyn, et al.. (2000). p38 Mitogen-activated Protein Kinase Regulates a Novel, Caspase-independent Pathway for the Mitochondrial Cytochromec Release in Ultraviolet B Radiation-induced Apoptosis. Journal of Biological Chemistry. 275(28). 21416–21421. 138 indexed citations
8.
Assefa, Zerihun, et al.. (1999). Signaling pathways in apoptosis induced by PDT with hypericin. Photochemistry and Photobiology. 69. 3 indexed citations
9.
Assefa, Zerihun, Annelies Vantieghem, Wim Declercq, et al.. (1999). The Activation of the c-Jun N-terminal Kinase and p38 Mitogen-activated Protein Kinase Signaling Pathways Protects HeLa Cells from Apoptosis Following Photodynamic Therapy with Hypericin. Journal of Biological Chemistry. 274(13). 8788–8796. 186 indexed citations
10.
Vantieghem, Annelies, Zerihun Assefa, Peter Vandenabeele, et al.. (1998). Hypericin‐induced photosensitization of HeLa cells leads to apoptosis or necrosis. FEBS Letters. 440(1-2). 19–24. 118 indexed citations
11.
Vandenbogaerde, Ann L., et al.. (1998). Cytotoxicity and Antiproliferative Effect of Hypericin and Derivatives after Photosensitization. Photochemistry and Photobiology. 67(1). 119–125. 90 indexed citations
12.
Vandenbogaerde, Ann L., et al.. (1998). Cytotoxicity and Antiproliferative Effect of Hypericin and Derivatives after Photosensitization. Photochemistry and Photobiology. 67(1). 119–119. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026